A study found that AP503 activates the GPR133 receptor, boosting bone formation and slowing bone loss in mice, with potential implications for osteoporosis and age-related muscle decline.
Experimental Compound Strengthens Bones in Mice by Activating GPR133
A study found that AP503 activates the GPR133 receptor, boosting bone formation and slowing bone loss in mice, with potential implications for osteoporosis and age-related muscle decline.
Bone density · Wikimedia — licence per file · rights
This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.
Monitoring item. The full text is not distributed. Extract and source below.